Vessel density, proliferation, and immunolocalization of vascular endothelial growth factor in juvenile nasopharyngeal angiofibromas

Archives of Otolaryngology - Head and Neck Surgery

Volumn 130, Issue 6, 2004, Pages 727-731

  Brieger, Jürgen ^a   Wierzbicka, Magorzata ^b   Sokolov, Maxim ^c   Roth, Yehudah ^c   Szyfter, Witold ^b   Mann, Wolf J ^a  

^a UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^b POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^c WOLFSON MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENIC FACTOR; CD31 ANTIGEN; KI 67 ANTIGEN; PARAFFIN; VASCULOTROPIN;

ADOLESCENT; ADULT; ANGIOGENESIS; ARTICLE; CANCER STAGING; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; CRYOPRESERVATION; FEMALE; HEMANGIOFIBROMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOLOCALIZATION; MALE; MICROSCOPY; NASOPHARYNX; NASOPHARYNX TUMOR; PROTEIN EXPRESSION; TUMOR VASCULARIZATION;

ADOLESCENT; ADULT; ANGIOFIBROMA; ENDOTHELIAL CELLS; HUMANS; KI-67 ANTIGEN; MALE; NASOPHARYNGEAL NEOPLASMS; NEOPLASM RECURRENCE, LOCAL; NEOVASCULARIZATION, PATHOLOGIC; STROMAL CELLS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 2642538583     PISSN: 08864470     EISSN: None     Source Type: Journal    
DOI: 10.1001/archotol.130.6.727     Document Type: Article

References (26)

1. Amedee R, Klaeyle D, Mann W, Geyer H. Juvenile angiofibromas: a 40-year surgical experience. ORL J Otorhinolaryngol Relat Spec. 1989;51:56-61.
2. Shikani AH, Richtsmeier WJ. Juvenile nasopharyngeal angiofibroma tumor models: failure of androgens to stimulate growth in nude mice and in vitro. Arch Otolaryngol Head Neck Surg. 1992;118:256-259.
3. Gates GA, Rice DH, Koopmann CF Jr, Schuller DE. Flutamide-induced regression of angiofibroma. Laryngoscope. 1992;102:641-644.
4. Gatalica Z. Immunohistochemical analysis of steroid hormone receptors in nasopharyngeal angiofibromas. Cancer Lett. 1998;127:89-93.
5. Hwang HC, Mills SE, Patterson K, Gown AM. Expression of androgen receptors in nasopharyngeal angiofibroma: an immunohistochemical study of 24 cases. Mod Pathol. 1998;11:1122-1126.
6. Schiff M, Gonzalez AM, Ong M, Baird A. Juvenile nasopharyngeal angiofibroma contain an angiogenic growth factor: basic FGF. Laryngoscope. 1992;102:940-945.
7. Nagai MA, Butugan O, Logullo A, Brentani MM. Expression of growth factors, proto-oncogenes, and p53 in nasopharyngeal angiofibromas. Laryngoscope. 1996;106(2, pt 1):190-195.
8. Dillard DG, Cohen C, Muller S, et al. Immunolocalization of activated transforming growth factor beta1 in juvenile nasopharyngeal angiofibroma. Arch Otolaryngol Head Neck Surg. 2000;126:723-725.
9. Folkman J. Role of angiogenesis in tumor growth and metastasis. Semin Oncol. 2002;29(6 suppl 16):15-18.
10. Plate KH, Breier G, Weich HA, et al. Vascular endothelial growth factor is a potential tumor angiogenesis factor in human gliomas in vivo. Nature. 1992;359:845-848.
11. Brown LF, Berse B, Jackman RW. Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in adenocarcinomas of the gastrointestinal tract. Cancer Res. 1993;53:4727-4735.
12. Brown LF, Berse B, Jackman RW. Increased expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in kidney and bladder carcinoma. Am J Pathol. 1993;143:1255-1262.
13. Brown LF, Berse B, Jackman RW. Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in breast cancer. Hum Pathol. 1995;26:86-91.
14. Jyung RW, LeClair EE, Bernat RA, et al. Expression of angiogenic growth factors in paragangliomas. Laryngoscope. 2000;110:161-167.
15. Dvorak HF, Brown LF, Detmar M, Dvorak AM. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol. 1995;146:1029-1039.
16. Fisch U. The infratemporal fossa approach for nasopharyngeal tumors. Laryngoscope. 1983;93:36-44.
17. Lissbrant IF, Lissbrant E, Persson A, Damber JE, Bergh A. Endothelial cell proliferation in male reproductive organs of adult rat is high and regulated by testicular factors. Biol Reprod. 2003;68:1107-1111.
18. Liu J, Wu S, Wei H, Zhou K, Ruan Y, Lai W. Effects of sex hormones and their balance on the proliferation of rat vascular endothelial cells. Horm Res. 2002;58:16-20.
19. Haggstrom S, Lissbrant IF, Bergh A, Damber JE. Testosterone induces vascular endothelial growth factor synthesis in the ventral prostate in castrated rats. J UroL 1999;161:1620-1625.
20. Gasparini G. Prognostic value of vascular endothelial growth factor in breast cancer. Oncologist. 2000;5:37-44.
21. Takahashi Y, Kitadai Y, Bucana CD, et al. Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis, and proliferation of human colon cancer. Cancer Res. 1995;55:3964-3968.
22. Kitadai Y, Haruma K, Tokutomi T, et al. Significance of vessel count and vascular endothelial growth factor in human esophageal carcinoma. Clin Cancer Res. 1998;4:2195-2200.
23. Arbiser ZK, Arbiser JL, Cohen C, et al. Neuroendocrine lung tumors: grade correlates with proliferation but not angiogenesis. Mod Pathol. 2001;14:1195-1199.
24. Juric G, Zarkovic N, Nola M, et al. The value of cell proliferation and angiogenesis in the prognostic assessment of ovarian granulosa cell tumors. Tumori. 2001;87:47-53.
25. Bocci G, Fasciani A, Danesi R, Viacava P, Genazzani AR, Del Tacca M. In-vitro evidence of autocrine secretion of vascular endothelial growth factor by endothelial cells from human placental blood vessels. Mol Hum Reprod. 2001;7:771-777.
26. Folkman J, Hahnfeldt P, Hlatky L. Cancer: looking outside the genome. Nat Rev Mol Cell Biol. 2000;1:76-79.